Development and validation of an artificial intelligence PIVKA-II-based model for the prediction of hepatocellular carcinoma development in patients with HCV-related cirrhosis successfully treated with direct-acting antivirals

被引：0
|
作者：
Caviglia, G. P. [1 ]
Fariselli, P. [2 ]
D'Ambrosio, R. [3 ]
Degasperi, E. [3 ]
Troshina, G. [1 ]
Nicolosi, A. [1 ]
Saracco, G. M. [1 ,4 ]
Lampertico, P. [3 ,5 ]
Ciancio, A. [1 ,4 ]
机构：
[1] Univ Turin, Dept Med Sci, Liver Unit, Turin, Italy
[2] Univ Turin, Dept Med Sci, Computat Biomed, Turin, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[4] Citta Salute & Sci Torino Molinette Hosp, Gastroenterol Unit, Turin, Italy
[5] Univ Milan, Dept Pathophysiol & Transplantat, CRC AM & Migliavacca Ctr Liver Dis, Milan, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2022年 / 54卷
关键词：
D O I：
10.1016/j.dld.2022.08.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC-01
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [41] Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia
    Chan, Patrick P. Y.
    Levy, Miriam T.
    Shackel, Nicholas
    Davison, Scott A.
    Prakoso, Emilia
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2020, 19 (06) : 541 - 546
  • [42] Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection
    Watanabe, Takao
    Tokumoto, Yoshio
    Joko, Kouji
    Michitaka, Kojiro
    Horiike, Norio
    Tanaka, Yoshinori
    Tada, Fujimasa
    Kisaka, Yoshiyasu
    Nakanishi, Seiji
    Yamauchi, Kazuhiko
    Yukimoto, Atsushi
    Nakamura, Yoshiko
    Hirooka, Masashi
    Abe, Masanori
    Hiasa, Yoichi
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (12) : 3507 - 3515
  • [43] Impact of viral eradication by direct-acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus-related compensated cirrhosis patients
    Nagaoki, Yuko
    Imamura, Michio
    Teraoka, Yuji
    Morio, Kei
    Fujino, Hatsue
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Hiramatsu, Akira
    Hayes, C. Nelson
    Chayama, Kazuaki
    Aikata, Hiroshi
    HEPATOLOGY RESEARCH, 2020, 50 (11) : 1222 - 1233
  • [44] Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia
    Patrick P Y Chan
    Miriam T Levy
    Nicholas Shackel
    Scott A Davison
    Emilia Prakoso
    Hepatobiliary & Pancreatic Diseases International, 2020, 19 (06) : 541 - 546
  • [45] PIVKA-II levels predict hepatocellular carcinoma development in caucasian HCV cirrhotic patients treated with DAAs
    Degasperi, Elisabetta
    Perbellini, Riccardo
    D'Ambrosio, Roberta
    Renteria, Sara Colonia Uceda
    Ceriotti, Ferruccio
    Perego, Alberto
    Orsini, Corinna
    Borghi, Marta
    Iavarone, Massimo
    Bruccoleri, Mariangela
    Rimondi, Alessandro
    Sangiovanni, Angelo
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2021, 75 : S784 - S784
  • [46] Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response
    Luan, Chih-Hsuan
    Su, Pin-Shuo
    Chu, Chi-Jen
    Lin, Chung-Chi
    Su, Chien-Wei
    Lee, Shou-Dong
    Wang, Yuan-Jen
    Lee, Fa-Yauh
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (09) : 795 - 805
  • [47] Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals
    Gardini, Andrea Casadei
    Conti, Fabio
    Foschi, Francesco Giuseppe
    Brillanti, Stefano
    Andreone, Pietro
    GASTROENTEROLOGY, 2018, 154 (08) : 2281 - 2282
  • [48] Development of hepatocellular carcinoma following HCV eradication by direct-acting antivirals: Real-life experience from Japanese multicenter cohort
    Ogawa, E.
    Furusyo, N.
    Hideyuki, N.
    Dohmen, K.
    Higashi, N.
    Takahashi, K.
    Kawano, A.
    Azuma, K.
    Satoh, T.
    Nakamuta, M.
    Koyanagi, T.
    Shimoda, S.
    Kato, M.
    Kajiwara, E.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S549 - S550
  • [49] CT EVALUATION OF SKELETAL MUSCLE MASS DYNAMICS FOLLOWING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH HCV-RELATED COMPENSATED CIRRHOSIS TREATED WITH DIRECT ACTING ANTIVIRALS
    Mihai, Florin
    Trifan, Anca
    Stanciu, Carol
    Huiban, Laura
    Muzica, Cristina Maria
    Ursulescu, Corina Lupascu
    Negru, Dragos
    Girleanu, Irina
    Cuciureanu, Tudor
    Singeap, Ana Maria
    GASTROENTEROLOGY, 2021, 160 (06) : S792 - S792
  • [50] Low serum zinc concentration is a risk for development of hepatocellular carcinoma and oral zinc supplementation decreases its risk in patients with HCV eradication by direct-acting antivirals
    Hosui, Atsushi
    Hiramatsu, Naoki
    HEPATOLOGY, 2017, 66 : 735A - 736A
12345